The Type 1 Diabetes PhysioLab® Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse
Lisl K.M. Shoda(Simulations Plus (United States)), Saroja Ramanujan(Unknown), David Young(Theranostics (New Zealand)), Huub T. C. Kreuwel, Yanan Zheng(Zhejiang Chinese Medical University), Kapil Gadkar(Sea Turtle Conservancy), Diane Mathis(Harvard University), Chan C. Whiting(Aduro BioTech (United States)), Mark A. Atkinson(University of Florida), Jeffrey A. Bluestone(University of California, San Francisco)
Cited by 55
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k